Carlo Lanza, MD, PhD
Executive Medical Officer
Carlo Lanza, MD, PhD, is Executive Medical Officer for Fortrea, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase I-IV clinical trials for Fortrea clients. He leads early phase and translational research early development programs with targeted therapies, small molecules, biologics and gene therapy. Dr. Lanza also oversees development of late-stage development strategies, delivery and approval of registrational programs. He brings more than 20 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology.
Before joining Fortrea, he served as Medical Director for Medicines for Malaria Venture in Geneva, Switzerland. Dr. Lanza has also held leadership positions with Novartis Oncology, Pfizer Global R&D, and AstraZeneca UK. Carlo joined our company in 2012.